Home \ Therapy \ The effectiveness of Mexidol in a patient with comorbidities: arterial hypertension, ischemic heart disease, cerebral ischemia

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
Comorbid patient and his features
00:52
The effect of metabolic syndrome on the brain
01:00
The risks of polypragmasia
01:20
Chronic brain ischemia and its combination with other symptoms
02:11
Multimodal effects for patients with metabolic syndrome

Evgeniya Viktorovna Yekusheva – Doctor of Medical Sciences, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation of the Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia

Announcement:

A comorbid patient is a patient encountered by physicians of virtually any specialty. These patients are characterized by the presence of several chronic diseases. Comorbid patients are especially common among the elderly. A classic example of such a patient is a patient with metabolic syndrome. It encompasses several conditions, including hypertension, obesity, dyslipidemia, and diabetes. The brain of a patient with metabolic syndrome is particularly susceptible to pathological processes. Therefore, one of the primary goals of physicians is to protect this neuronal structure. Mexidol® is often used in this task. The use of Mexidol® in ischemia, hypertension, and other conditions helps prevent complications.

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
Comorbid patient and his features
00:52
The effect of metabolic syndrome on the brain
01:00
The risks of polypragmasia
01:20
Chronic brain ischemia and its combination with other symptoms
02:11
Multimodal effects for patients with metabolic syndrome

Block of articles on this topic

Personal: International multicenter randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250: Subanalysis results in patients with arterial hypertension

Authors:
V.V. ZAKHAROV¹, O.D. OSTROUMOVA^1,2, A.I. KOCHETKOV², M.V. KLEPIKOVA², A.I. FEDIN³

The results of clinical studies of the effectiveness and safety of the use of ethylmethylhydroxypyridine of succinate in patients with chronic brain ischemia

Authors:
M.V. ZHURAVLEVA^1,2, P.R. KAMCHATNOV³, N.S. VASYUKOVA⁴, V.V. ARKHIPOV¹, E.V. KUZNETSOVA⁵, T.R. KAMENEVA⁶, S.Yu. SEREBROVA^1,2

Mexidol® and Mexidol® Fort 250 as part of the sequential therapy for cognitive disorders in comorbide patients with joint pathology against the background of arterial hypertension and coronary heart disease

L.N. Eliseeva, S.V. Kartashova

FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar

The influence of Mexidol on the improvement of cognitive status and quality parameters as part of the complex therapy of patients with chronic heart failure of the II - III functional class

Author:
TOLKACHEVA V.V., KARAPETYAN L.V., KHUTSISHVILI N.I., GALOCHKIN S.A., KAZAKHMEDOV E.R., KOBALAVA Zh.D.

FGAOU in Russian University of Friendship of Peoples named after Patrice Lumumba, Moscow, Russia

Mexidol effects in patients with chemical and heart failure II - III functional class

Authors:
A.V. SHCHULKIN², E.R. KAZAKHMEDOV¹, S.A. GALOCHKIN¹, V.V. TOLKACHEVA¹, J.D. KOBALAVA¹

¹Peoples' Friendship University of Russia, Moscow;
²Ryazan State Medical University named after Academician I.P. Pavlov of the Ministry of Health of the Russian Federation, Ryazan

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com